CLINICAL AND ECONOMIC EFFECTIVENESS OF SUPPORTING THERAPY OF ASTHMA

Clinical and social efficiency of three different treatments of supporting therapy of Asthma of 102 patients at the age of 18–22 with moderately severe disease without concomitant pathology has been correlated in a prospective way. Observation over the patients has been carried out during a year. Minimal clinical efficiency was obvious when inhalation corticosteroids were selectively used. The patients receiving the combination of inhalation corticosteroids and beta – 2-adrenoagonists have completely comparable clinical effectiveness. Expenses on the taking of fixed combinations of mentioned medicines exceed expenditures on their wandering combinations.